Defects in embryonic development of EGLN1/PHD2 knockdown transgenic mice are associated with induction of Igfbp in the placenta

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 372-376

  Ozolinš, Terence R S ^a   Fisher, Timothy S ^b   Nadeau, Diane M ^b   Stock, Jeffrey L ^b   Klein, Anne S ^b   Milici, Anthony J ^b   Morton, Daniel ^b   Wilhelms, Margaret B ^b   Brissette, William H ^b   Li, Baiyong ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b PFIZER INC   (United States)

Author keywords

Embryonic development; HIF; Hydroxylase; RNAi; Transgenic mice

Indexed keywords

ERYTHROPOIETIN; OXYGENASE; PROTEIN EGLN1; SOMATOMEDIN BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME INHIBITION; ERYTHROPOIESIS; MOUSE; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; TRANSGENIC MOUSE;

ANIMALS; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; FEMALE; HEART; HEART DEFECTS, CONGENITAL; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; LIVER; MICE; MICE, TRANSGENIC; MYOCARDIUM; PLACENTA; PREGNANCY; PROCOLLAGEN-PROLINE DIOXYGENASE;

LENTIVIRUS; MURINAE; MUS; MUS MUSCULUS;

EID: 70449729333     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.057     Document Type: Article

References (27)

1. Semenza G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15 (1999) 551-578
2. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12 (1998) 149-162
3. Semenza G.L. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88 (2000) 1474-1480
4. 2 tension. Proc. Natl. Acad. Sci. USA 92 (1995) 5510-5514
5. Salceda S., and Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272 (1997) 22642-22647
6. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95 (1998) 7987-7992
7. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., and Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
8. Berra E., Roux D., Richard D.E., and Pouyssegur J. Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm. EMBO Rep. 2 (2001) 615-620
9. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., and Kaelin Jr. W.G. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292 (2001) 464-468
10. 2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
11. Masson N., Willam C., Maxwell P.H., Pugh C.W., and Ratcliffe P.J. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J. 20 (2001) 5197-5206
12. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., and Ratcliffe P.J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
13. Ivan M., Haberberger T., Gervasi D.C., Michelson K.S., Gunzler V., Kondo K., Yang H., Sorokina I., Conaway R.C., Conaway J.W., and Kaelin Jr. W.G. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA 99 (2002) 13459-13464
14. Bruick R.K., and McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294 (2001) 1337-1340
15. Hewitson K.S., McNeill L.A., Riordan M.V., Tian Y.M., Bullock A.N., Welford R.W., Elkins J.M., Oldham N.J., Bhattacharya S., Gleadle J.M., Ratcliffe P.J., Pugh C.W., and Schofield C.J. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277 (2002) 26351-26355
16. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., and Bruick R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16 (2002) 1466-1471
17. Lando D., Peet D.J., Whelan D.A., Gorman J.J., and Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295 (2002) 858-861
18. Takeda K., Ho V.C., Takeda H., Duan L.J., Nagy A., and Fong G.H. Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Mol. Cell. Biol. 26 (2006) 8336-8346
19. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., Rooney D.L., Ihrig M.M., McManus M.T., Gertler F.B., Scott M.L., and Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33 (2003) 401-406
20. Kissler S., Stern P., Takahashi K., Hunter K., Peterson L.B., and Wicker L.S. In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nat. Genet. 38 (2006) 479-483
21. Ben Lagha N., Seurin D., Le Bouc Y., Binoux M., Berdal A., Menuelle P., and Babajko S. Insulin-like growth factor binding protein (IGFBP-1) involvement in intrauterine growth retardation: study on IGFBP-1 overexpressing transgenic mice. Endocrinology 147 (2006) 4730-4737
22. Crossey P.A., Pillai C.C., and Miell J.P. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J. Clin. Invest. 110 (2002) 411-418
23. Gay E., Seurin D., Babajko S., Doublier S., Cazillis M., and Binoux M. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth. Endocrinology 138 (1997) 2937-2947
24. Rajkumar K., Barron D., Lewitt M.S., and Murphy L.J. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 136 (1995) 4029-4034
25. Watson C.S., Bialek P., Anzo M., Khosravi J., Yee S.P., and Han V.K. Elevated circulating insulin-like growth factor binding protein-1 is sufficient to cause fetal growth restriction. Endocrinology 147 (2006) 1175-1186
26. Kajimura S., Aida K., and Duan C. Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation. Proc. Natl. Acad. Sci. USA 102 (2005) 1240-1245
27. Carter A.M., Nygard K., Mazzuca D.M., and Han V.K. The expression of insulin-like growth factor and insulin-like growth factor binding protein mRNAs in mouse placenta. Placenta 27 (2006) 278-290